Susquehanna International »

Elicio Therapeutics shares owned by Susquehanna International

Quarter-by-quarter ownership of Elicio Therapeutics (ELTX) shares owned by Susquehanna International from 13F filings

Historical chart of Susquehanna International investment in Elicio Therapeutics

Tip: Access up to 7 years of quarterly data

All positions including Elicio Therapeutics held by Susquehanna International consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Elicio Therapeutics by Susquehanna International

Quarter filed Position value Share count Share price at filing
2025-09-30 $1.3M 120k 10.94
2025-06-30 $131k 17k 7.72
2025-03-31 $193k 31k 6.16

More positions owned by Susquehanna International

Spdr S&p 500 Etf Tr Tr Unit (SPY)
Tesla Motors (TSLA)
NVIDIA Corporation (NVDA)
Invesco Qqq Tr Unit Ser 1 (QQQ)
Apple (AAPL)
Microsoft Corporation (MSFT)
Meta Platforms Cl A (META)
Ishares Tr Russell 2000 Etf (IWM)
Amazon (AMZN)
UnitedHealth (UNH)
Netflix (NFLX)
Alphabet Cap Stk Cl A (GOOGL)
Spdr Gold Tr Gold Shs (GLD)
Palantir Technologies Cl A (PLTR)
Broadcom (AVGO)

View all positions for Susquehanna International

Top funds holding Elicio Therapeutics

Knoll Capital Management
Vanguard Group
Balyasny Asset Management
Geode Capital Management
Susquehanna International
Caption Management
Marshall Wace
Northern Trust
Renaissance Technologies
BlackRock
State Street Corporation
Cresset Asset Management
Millennium Management
Citadel Advisors
Leucadia National Corporation

View all funds holding Elicio Therapeutics